Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Tiopronin products98.33M67.70%
FILSPARI29.21M20.11%
License and collaboration revenue17.7M12.19%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States145.24M100.00%